AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Truqap (capivasertib) by Year
Truqap (capivasertib) — Established RoW product sales ($M) ($M)
AstraZeneca Truqap (capivasertib): $34M in FY2025, up 325.0% from a year earlier.
Latest, FY2025
34
Period ended Dec 31, 2025
Change on a year earlier
+325.0%
8 in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Truqap | 728 | 69 | 68 | 586 | 44 | 23 | n/m | n/m | 85 | n/m | n/m | 34 | n/m | n/m”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Truqap (capivasertib) — Established RoW product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34 | +325.0% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 8 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 0 | – | Form 6-K FY2023Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Truqap (capivasertib) ($M), annual FY2023–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-truqap-erow
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.